BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Mylan Inc. (MYL) in Talks to Buy Parts of SMS Pharma


9/14/2012 7:17:23 AM

Mylan, the second-largest US generic drug firm with annual sales of over $6 billion, is in late-stage talks with the Hyderabad-based SMS Pharma to acquire a part of its business. Sources said the US giant is keen on SMS units manufacturing lucrative cancer therapy drugs — both raw materials and finished drugs — and others. “The two companies are in the final stages of negotiations and a deal may be finalised shortly. The part of the business Mylan proposes to buy from SMS Pharma is one of the most advanced oncology facilities in the country, providing almost end-to-end solutions in cancer therapies.


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->